产品中心Cell Resources
联系我们CONTACT US
- 400-999-210024小时服务热线
产品概述
名称 | SW872 (人脂肪肉瘤细胞) (STR鉴定正确) |
别称 | SW-872; SW 872 |
种属 | 人类 |
生长特性 | 贴壁细胞 |
细胞形态 | 成纤维细胞样 |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:
培养条件:
气相:空气,100%, 温度:37℃
|
培养方案B(可选) |
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
|
推荐传代比例 | 1:3-1:5 |
推荐换液频率 | 2-3次/周 |
注意事项 | 1.该细胞推荐使用Leibovitz's L-15培养基进行培养,Leibovitz's L-15不可以通入二氧化碳,会产生细胞毒性;2.如您没有无二氧化碳的培养箱,可使用DMEM替代Leibovitz's L-15,使用DMEM培养基时即可正常通入5%二氧化碳;3.配套专用培养基默认Leibovitz's L-15配置,如需DMEM配方,请联系销售下单备注更改。 |
背景描述 | The SW 872 cell line was initiated by A. Leibovitz in 1974 at the Scott and White Clinic, Temple, Texas from a surgical specimen of a fibrosarcoma removed from a 36 year old male Caucasian. |
年龄(性别) | 男性;36岁 |
组织来源 | 结缔组织 |
肿瘤类型 | 肉瘤细胞 |
生物安全等级 | BSL-1 |
倍增时间 | ~24 hours |
致瘤性 | Yes |
抗原表达情况 | Blood type O+ |
保藏机构 | ATCC; HTB-92 BCRC; 60432 |
STR鉴定
-
STR位点信息
Amelogenin X CSF1PO 10 D2S1338 17,21 D3S1358 16 D5S818 12,13 D7S820 8,11 D8S1179 12,15 D13S317 11 D16S539 9,12 D18S51 12,16 D19S433 13,14 D21S11 27,31.2 FGA 21.2,23 PentaD 9,10 PentaE 5,10 TH01 8,10 TPOX 8,11 vWA 17 D6S1043 12,20 D12S391 18 D2S441 10,11 -
STR鉴定图
参考文献
-
Beating xenograft liposarcoma using metal selenides with NIR-III photothermal ablation and bioactive selenium derivates (2024-01-03)
作者:Jiulong Zhang: 1.Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China; Wen Ye: 1.Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China; Lei Wan: 1.Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China; Nannan Shi: 1.Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China; Chen Peng: 1.Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China; Yuxin Shi: 1.Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China; Zhiyong Zhang: 1.Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China;2.Shanghai Institute of Medical Imaging, Fudan University, Shanghai, 200237, China; Nuo Yu: 1.Department of Radiology, Shanghai Public Health Clinical Center
期刊:Beating xenograft liposarcoma using metal selenides with NIR-III photothermal ablation and bioactive selenium derivates
影响因子 :15.1
-
Identification of anoikis-related molecular patterns to define tumor microenvironment and predict immunotherapy response and prognosis in soft-tissue sarcoma (2023-03-01)
作者:Lin Qi:1.Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China. ; 2.Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Changsha, China. ; Fangyue Chen:1.Department of General Surgery, Changhai Hospital, Navy Military Medical University, Shanghai, China. ; Lu Wang:1.Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China. ; 2.Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Changsha, China. ; Zhimin Yang:1.Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China. ; 2.Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Changsha, China. ; 3.Department of Microbiology, Immunology & Molecular Genetics, University of Texas Long School of Medicine, UT Health Science Center, San Antonio, TX, United States. ; Wenchao Zhang:1.Department
期刊:Identification of anoikis-related molecular patterns to define tumor microenvironment and predict immunotherapy response and prognosis in soft-tissue sarcoma
DOI:10.3389/fphar.2023.1136184
影响因子 :5.6
引用产品: SW 982 [SW-982; SW982] 细胞 , SW872 细胞
-
Integrated Analysis of TME and Hypoxia Identifies a Classifier to Predict Prognosis and Therapeutic Biomarkers in Soft Tissue Sarcomas (2022-11-18)
作者:Ruiling Xu:1.Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha 410010, China. ; 2.Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Changsha 410010, China. ; Lin Qi:1.Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha 410010, China. ; 2.Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Changsha 410010, China. ; Xiaolei Ren:1.Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha 410010, China. ; 2.Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Changsha 410010, China. ; Wenchao Zhang:1.Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha 410010, China. ; 2.Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Changsha 410010, China. ; Chenbei Li:1.Departm
期刊:Integrated Analysis of TME and Hypoxia Identifies a Classifier to Predict Prognosis and Therapeutic Biomarkers in Soft Tissue Sarcomas
影响因子 :6.6
引用产品: SW872 细胞
FAQs
Q:{{item.question}}
A:
产品资料
识别码示意图